Wei, Sung-Hsi <br/><br/>
The safety and immunogenicity of a MF59-adjuvanted H5N1 prepandemic influenza vaccine in healthy adults primed with homologous or heterologous H5N1 vaccines: an observational study.  [electronic resource] 

 -  BMC infectious diseases  Nov 2014 
 - 587 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1471-2334 
<br/><br/><label>Standard No.: </label>10.1186/s12879-014-0587-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adjuvants, Immunologic--therapeutic use<br/>Adult<br/>Antibodies, Viral--blood<br/>Antibody Formation<br/>Female<br/>Hemagglutination Inhibition Tests<br/>Humans<br/>Immunization, Secondary<br/>Influenza A Virus, H5N1 Subtype--immunology<br/>Influenza Vaccines--immunology<br/>Influenza, Human--prevention & control<br/>Male<br/>Middle Aged<br/>Pandemics<br/>Polysorbates--therapeutic use<br/>Squalene--immunology<br/>Vaccination<br/>Vietnam<br/>World Health Organization<br/>Young Adult